Woundcare Technology Day

Advanced Medical Solutions Grp PLC
26 May 2004


For Immediate Release                                   Wednesday 26th May, 2004

         Advanced Medical Solutions Group plc ('AMS' or 'the Company')

                            Woundcare Technology Day

Winsford, UK: Advanced Medical Solutions (AIM: AMS), the global woundcare
technology company, announces that it will hold a Technology Day on Wednesday
9th June 2004 at Buchanan Communications, 107 Cheapside, London, EC2V 6DN, from
10:30am to 12:30pm followed by lunch.

Fund managers, analysts and the media will be invited to attend the session
which will consist of an overview of the Group's R & D programme and strategy by
Chief Executive Don Evans, followed by presentations on the technology pipelines
for the advanced woundcare and wound closure businesses.

                                     -ENDS-

For further information, please contact:

Advanced Medical Solutions Group plc                  Tel : [phone]
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com

Buchanan Communications                               Tel: [phone]
Mark Court, Mary-Jane Johnson

Notes to Editors:

Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $15 billion global woundcare market.

Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.

In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.

The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives and sealants sold direct to hospitals or
through distributors.

AMS's technology and products currently serve the majority of the key global
markets with strategic partners including 3M, Novartis, Johnson & Johnson Inc,
Molnlycke Healthcare, Coloplast, Smith & Nephew and Beiersdorf




                      This information is provided by RNS
            The company news service from the London Stock Exchange